NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









PolyVascular, Inc.

PolyVascular, Inc.

Private
Houston, TexasHealthcare & Life Scienceshttps://polyvascular.com/

Last Round

Grant

Apr 24, 2025

Total Funding Raised

$5M

Company Overview

PolyVascular, Inc. is a medical device company that develops minimally invasive, polymeric transcatheter heart valves for children with congenital heart disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

transcatheter heart valvepediatric cardiologycongenital heart diseaseminimally invasive surgerymedical devicepulmonary valve replacementheart valvebiocompatible polymerpediatric medical devicecatheter deliverysurgical implantclass III medical deviceinterventional cardiologystructural heartmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PolyVascular, Inc. Comparables

Compare PolyVascular, Inc. with similar companies based on industry and business-model similarity.

PolyVascular, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Autus Valve Technologies, Inc.
93%
PECA Labs, Inc.
87%
Tremedics Medical Devices
79%

PolyVascular, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 24, 2025
SeedAug 29, 2023
GrantJul 12, 2023
GrantMar 30, 2021
AcceleratorJun 16, 2020
Grant
Mar 8, 2019

PolyVascular, Inc. Investors

Notable investors and investment history

PolyVascular, Inc. investors
InvestorRounds
CobiCure MedTechGrant
MedTech InnovatorAccelerator
NIH RADxGrant
SWPDCGrant
National Heart, Lung, and Blood InstituteGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 24, 2025

    $3M awarded by National Heart, Lung, and Blood Institute.

  • Aug 29, 2023

    $750K raised in Seed round.

PolyVascular, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

PolyVascular, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PolyVascular, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersHouston, Texas
Employee Range11
Year Founded2014
Last FundingApr 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.